Quanterix (QTRX) Cash from Financing Activities (2017 - 2026)
Quanterix's (QTRX) quarterly Cash from Financing Activities came in at -$770000.0 in Q1 2026, down 927.96% YoY from $93000.0 in Q1 2025, and down 47.51% on a QoQ basis from -$522000.0 in Q4 2025.
Quanterix (QTRX) Cash from Financing Activities (2017 - 2026) Analysis & Trends
Quanterix (QTRX) has 10 years of Cash from Financing Activities data on file, last reported at -$770000.0 in Q1 2026.
- Quarterly Cash from Financing Activities fell 927.96% year-over-year to -$770000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.6 million (down 3042.0% YoY) and the FY2025 annual result came in at -$708000.0, down 255.26% from the prior year.
- Cash from Financing Activities fell to -$770000.0 in Q1 2026, from -$522000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $1.8 million in Q3 2023 to a low of -$770000.0 in Q1 2026.
- A 5-year average of $234117.6 and a median of $150000.0 in 2025 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2023 — Cash from Financing Activities surged 342.26% — and 2025, when it slumped 1373.17%.
- Tracing QTRX's Cash from Financing Activities over 5 years: stood at $714000.0 in 2022, then sank by 71.85% to $201000.0 in 2023, then plunged by 79.6% to $41000.0 in 2024, then tumbled by 1373.17% to -$522000.0 in 2025, then slumped by 47.51% to -$770000.0 in 2026.
- The last three Cash from Financing Activities figures came in at -$770000.0 (Q1 2026), -$522000.0 (Q4 2025), and $150000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Quanterix | 141.97 Mn | 48.44 Mn | 12.67 Mn | -527,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -527,000.00 |
| Jun 30, 2026 | -527,000.00 |
| Mar 31, 2026 | -770,000.00 |
| Mar 31, 2026 | -770,000.00 |
| Dec 31, 2025 | -522,000.00 |
| Dec 31, 2025 | -522,000.00 |
| Sep 30, 2025 | 150,000.00 |
| Sep 30, 2025 | 150,000.00 |
| Jun 30, 2025 | -429,000.00 |
| Jun 30, 2025 | -429,000.00 |
| Mar 31, 2025 | 93,000.00 |
| Mar 31, 2025 | 93,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Sep 30, 2024 | 144,000.00 |
| Sep 30, 2024 | 144,000.00 |
| Jun 30, 2024 | -328,000.00 |
| Jun 30, 2024 | -328,000.00 |
| Mar 31, 2024 | 599,000.00 |
| Mar 31, 2024 | 599,000.00 |